Lessons from Exceptional Responders with High-Grade Brain Tumors Treated with Precision Targeted Therapies

20260 citationsJournal Articlegold Open Access

Authors

Umut Dişel · Acıbadem Adana Hospital

Shumei Kato · Moores Cancer Center

Aditya Shreenivas · City of Hope

Ayca Ersen Danyeli · Acıbadem University

M. Ahluwalia · Baptist Hospital of Miami

Razelle Kurzrock · Froedtert Hospital

Abstract

Our exceptional responders with high-grade gliomas suggest that biomarker-matched targeted therapy can benefit select patients with high-grade glioma and warrants prospective clinical trials.

Topics & Keywords

Glioma Diagnosis and Treatment Neurofibromatosis and Schwannoma Cases PI3K/AKT/mTOR signaling in cancer

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Immunotherapy and Precision Oncology

Volume 9, Issue 1, pp. 25-31

DOI: 10.36401/jipo-25-34

Field-Weighted Citation Impact: 0.00